These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 32949395)
41. ARHI (DIRAS3) induces autophagy in ovarian cancer cells by downregulating the epidermal growth factor receptor, inhibiting PI3K and Ras/MAP signaling and activating the FOXo3a-mediated induction of Rab7. Lu Z; Yang H; Sutton MN; Yang M; Clarke CH; Liao WS; Bast RC Cell Death Differ; 2014 Aug; 21(8):1275-89. PubMed ID: 24769729 [TBL] [Abstract][Full Text] [Related]
42. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma. Li Z; Zhang H; Yang J; Hao T; Li S Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295 [TBL] [Abstract][Full Text] [Related]
43. Loss of ARHI expression in colon cancer and its clinical significance. Wang W; Chen L; Tang Q; Fan Y; Zhang X; Zhai J Contemp Oncol (Pozn); 2014; 18(5):329-33. PubMed ID: 25477755 [TBL] [Abstract][Full Text] [Related]
44. ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts. Washington MN; Suh G; Orozco AF; Sutton MN; Yang H; Wang Y; Mao W; Millward S; Ornelas A; Atkinson N; Liao W; Bast RC; Lu Z Cell Death Dis; 2015 Aug; 6(8):e1836. PubMed ID: 26247722 [TBL] [Abstract][Full Text] [Related]
45. CpG island methylator phenotypes in aging and cancer. Toyota M; Issa JP Semin Cancer Biol; 1999 Oct; 9(5):349-57. PubMed ID: 10547343 [TBL] [Abstract][Full Text] [Related]
46. Regulation of AURKC expression by CpG island methylation in human cancer cells. Fujii S; Srivastava V; Hegde A; Kondo Y; Shen L; Hoshino K; Gonzalez Y; Wang J; Sasai K; Ma X; Katayama H; Estecio MR; Hamilton SR; Wistuba I; Issa JP; Sen S Tumour Biol; 2015 Sep; 36(10):8147-58. PubMed ID: 25990457 [TBL] [Abstract][Full Text] [Related]
47. Unusual distribution of DNA methylation within the hTERT CpG island in tissues and cell lines. Guilleret I; Benhattar J Biochem Biophys Res Commun; 2004 Dec; 325(3):1037-43. PubMed ID: 15541393 [TBL] [Abstract][Full Text] [Related]
48. Analysis of promoter CpG island hypermethylation in cancer: location, location, location! van Vlodrop IJ; Niessen HE; Derks S; Baldewijns MM; van Criekinge W; Herman JG; van Engeland M Clin Cancer Res; 2011 Jul; 17(13):4225-31. PubMed ID: 21558408 [TBL] [Abstract][Full Text] [Related]
49. Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumors. Dalai I; Missiaglia E; Barbi S; Butturini G; Doglioni C; Falconi M; Scarpa A Neoplasia; 2007 Mar; 9(3):181-3. PubMed ID: 17401457 [TBL] [Abstract][Full Text] [Related]
51. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer. Wang L; Hoque A; Luo RZ; Yuan J; Lu Z; Nishimoto A; Liu J; Sahin AA; Lippman SM; Bast RC; Yu Y Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3660-6. PubMed ID: 14506155 [TBL] [Abstract][Full Text] [Related]
52. The role of DNA hypermethylation in human neoplasia. Toyota M; Issa JP Electrophoresis; 2000 Jan; 21(2):329-33. PubMed ID: 10675010 [TBL] [Abstract][Full Text] [Related]
53. Hypermethylation and clinicopathological significance of RASAL1 gene in gastric cancer. Chen H; Pan Y; Cheng ZY; Wang Z; Liu Y; Zhao ZJ; Fan H Asian Pac J Cancer Prev; 2013; 14(11):6261-5. PubMed ID: 24377515 [TBL] [Abstract][Full Text] [Related]
54. Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway. Bao JJ; Le XF; Wang RY; Yuan J; Wang L; Atkinson EN; LaPushin R; Andreeff M; Fang B; Yu Y; Bast RC Cancer Res; 2002 Dec; 62(24):7264-72. PubMed ID: 12499268 [TBL] [Abstract][Full Text] [Related]
55. EZH2-induced H3K27me3 is associated with epigenetic repression of the ARHI tumor-suppressor gene in ovarian cancer. Fu Y; Chen J; Pang B; Li C; Zhao J; Shen K Cell Biochem Biophys; 2015 Jan; 71(1):105-12. PubMed ID: 25077680 [TBL] [Abstract][Full Text] [Related]
56. Hypermethylation of the CpG island of the RASSF1A gene in ovarian and renal cell carcinomas. Yoon JH; Dammann R; Pfeifer GP Int J Cancer; 2001 Oct; 94(2):212-7. PubMed ID: 11668500 [TBL] [Abstract][Full Text] [Related]
57. Correlation between CpG methylation profiles and hormone receptor status in breast cancers. Feng W; Shen L; Wen S; Rosen DG; Jelinek J; Hu X; Huan S; Huang M; Liu J; Sahin AA; Hunt KK; Bast RC; Shen Y; Issa JP; Yu Y Breast Cancer Res; 2007; 9(4):R57. PubMed ID: 17764565 [TBL] [Abstract][Full Text] [Related]
58. Homo sapiens lactate dehydrogenase c (Ldhc) gene expression in cancer cells is regulated by transcription factor Sp1, CREB, and CpG island methylation. Tang H; Goldberg E J Androl; 2009; 30(2):157-67. PubMed ID: 18930904 [TBL] [Abstract][Full Text] [Related]
59. Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer. Soejima H; Nakagawachi T; Zhao W; Higashimoto K; Urano T; Matsukura S; Kitajima Y; Takeuchi M; Nakayama M; Oshimura M; Miyazaki K; Joh K; Mukai T Oncogene; 2004 May; 23(25):4380-8. PubMed ID: 15007390 [TBL] [Abstract][Full Text] [Related]
60. Predicting aberrant CpG island methylation. Feltus FA; Lee EK; Costello JF; Plass C; Vertino PM Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12253-8. PubMed ID: 14519846 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]